Modalis Therapeutics Corporation (TYO:4883)
57.00
-1.00 (-1.72%)
Apr 3, 2026, 3:30 PM JST
Modalis Therapeutics Employees
Modalis Therapeutics had 17 employees as of December 31, 2025. The number of employees increased by 3 or 21.43% compared to the previous year.
Employees
17
Change (1Y)
3
Growth (1Y)
21.43%
Revenue / Employee
n/a
Profits / Employee
-126.59M JPY
Market Cap
4.99B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 3 | 21.43% |
| Dec 31, 2024 | 14 | -23 | -62.16% |
| Dec 31, 2023 | 37 | 1 | 2.78% |
| Dec 31, 2022 | 36 | 10 | 38.46% |
| Dec 31, 2021 | 26 | 6 | 30.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Nippon Chemiphar | 855 |
| Pharma Foods International | 613 |
| WDB coco | 566 |
| Morishita Jintan | 356 |
| Taiko Pharmaceutical | 214 |
| SymBio Pharmaceuticals | 91 |
| Solasia Pharma K.K. | 23 |
| MedRx | 22 |
Modalis Therapeutics News
- 10 months ago - SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy - Financial Post